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1
. Mammals synthesize D-Ser and D-Asp, primarily in the central nervous system, where D-Ser is critical for neurotransmission 2 . Bacteria synthesize a largely distinct set of D-aa, which become integral components of the cell wall and are also released as free D-aa 3,4 . However, the impact of free microbial D-aa on host physiology at the host-microbial interface has not been explored. Here, we show that the mouse intestine is rich in free D-aa that are derived from the microbiota. Furthermore, the microbiota induces production of D-amino acid oxidase (DAO) by intestinal epithelial cells, including goblet cells, which secrete the enzyme into the lumen. Oxidative deamination of intestinal D-aa by DAO, which yields the antimicrobial product H 2 O 2 , protects the mucosal surface in the small intestine from the cholera pathogen. DAO also modifies the composition of the microbiota and is associated with microbial induction of intestinal sIgA. Collectively, these results identify D-aa and DAO as previously unrecognized mediators of microbe-host interplay and homeostasis on the epithelial surface of the small intestine.
Mammals recognize and respond to diverse microbial products, including fragments of the cell wall 5, 6 . However, the prevalence and role of free microbial D-aa on host physiology in the intestinal milieu has not been explored. Given the abundance and diversity of bacteria present in the mammalian intestinal tract 7 , we first assessed if microbe-generated free D-amino acids (D-aa) are present within the intestine. D-and L-forms of all proteinogenic amino acids were quantified by two-dimensional HPLC 8 in the caecal contents of specific pathogen-free (SPF) mice and germ-free (GF) mice. D-Ala, D-Asp, D-Glu and D-Pro were detected in SPF mice (∼200-500 nmol g -1 ), but the caeca of GF mice contained only low levels of D-Asp (Fig. 1a,c) . In contrast, abundant L-amino acids were detected in both SPF and GF animals, but caecal L-amino acid levels were generally lower in SPF mice compared with GF mice (Fig. 1b) , probably due to their utilization by the gut microbiota. Chow for SPF and GF mice contained comparable amounts of D/ L-aa, and was thus not responsible for the disparity between GF and SPF animals in intestinal amino acid content ( Supplementary  Fig. 1a,b ). These observations, coupled with knowledge regarding host D-aa synthesis 9 , strongly suggest that free D-aa in the murine intestinal tract are primarily microbial products.
In mammals, endogenous D-aa levels are regulated by the action of D-amino acid oxidase (DAO), which converts neutral D-aa, such as D-Ser, into H 2 O 2 and α-keto acids 10 . Given the abundance of microbiota-derived D-aa in the gut, we asked whether DAO, which is known to be primarily expressed in the central nervous system (CNS) and kidney 10 , is also present in the intestine. Using an activity-based assay 11 , we detected DAO exclusively associated with the villous epithelium of the small intestine (SI) of SPF mice (Fig. 2a,b and Supplementary Fig. 2a,b) . Immunoblotting confirmed the presence of DAO in the proximal and middle SI and its absence from other regions of the gastrointestinal (GI) tract ( Fig. 2c and Supplementary Fig. 2c,d ). In the proximal SI, DAO activity was detected primarily near the apical border of enterocytes and in goblet cells, and in the middle SI, DAO activity was observed in both secretory vesicles of goblet cells and in mucus ( Fig. 2d and Supplementary Fig. 2b,f,g ). DAO was also detected within human goblet cells, and its presence in human small intestinal lysates was confirmed using immunoprecipitation and immunoblotting ( Fig. 2e and Supplementary Fig. 3 ). These data demonstrate the expression of active DAO in the mouse and human intestine and that, in contrast to its peroxisomal localization in CNS astrocytes 10 , some portion of intestinal DAO appears to be secreted into the lumen by goblet cells (Fig. 2d and Supplementary Fig. 2e-g ). Bioinformatic analyses of the murine and human DAO amino acid sequences revealed the presence of a signal peptide and a predicted cleavage site near their respective N termini, consistent with them being secreted proteins ( Supplementary Fig. 4 ).
We investigated whether the microbiota, which generates the substrates for DAO, also influences the production of intestinal DAO, and found that the enterocytes and goblet cells of SPF mice contained far more DAO than those of GF mice ( Fig. 2f and Supplementary Fig. 5a-c) . Conventionalization of GF mice induced DAO to nearly the levels observed in SPF animals ( Fig. 2f and Supplementary Fig. 6a,b) , providing additional support for the idea that the microbiota modulates production of DAO in the intestine. In particular, a vancomycin-sensitive subset of the microbiota appears linked to DAO production, both in conventionalized GF mice and in SPF mice, as DAO levels were markedly lower in animals treated with vancomycin than in untreated controls ( Fig. 2f and Supplementary Fig. 6a-c) . DAO levels were not reduced in the CNS or kidneys of GF mice relative to wild-type (WT) mice, suggesting that microbiota control of DAO expression is limited to the intestine ( Supplementary Fig. 5d,e ). The precise pathways by which the microbiota regulates DAO production in the intestine are unknown; however, induction appears to be largely independent of MyD88 and RIPK2, which mediate two major innate immune recognition pathways 12 ( Supplementary  Fig. 6d ). Using mice harbouring a natural point mutation (DAO G181R ) that abolishes DAO activity 13 , we assessed whether DAO modulates intestinal D-aa content. In the proximal SI, where DAO activity is high, WT mice had lower luminal, mucosal and intra-epithelial concentrations of D-Ala compared to DAO G181R animals ( Fig. 2g and Supplementary Fig. 1c,e,g ). Differences were particularly marked for the mucosal and epithelial samples, compared to within the lumen, consistent with the fact that DAO activity requires oxygen, which is more readily available near the epithelial surface 14 . In contrast, SI samples from WT and mutant mice contained similar levels of D-Asp and D-Glu, which are not oxidized Supplementary Fig. 6a,b) . Specific pathogen-free (SPF), germ-free (GF), GF with SPF bedding (GF-SPF) and vancomycin-treated GF-SPF (GF-SPF-V) mice were assessed (n = 3 mice each). g, Abundance of D-Ala in epithelial, mucosal and luminal samples from proximal SI of DAO WT and DAO G181R mice (n = 6 mice each). Error bars, mean ± s.e.m. *P < 0.05, **P < 0.01 and ***P < 0.001, analysed with one-way ANOVA (f) or Wilcoxon rank-sum test (g).
by DAO, as well as L-aa ( Supplementary Fig. 1c-h ). Consistent with the absence of DAO expression in the colon, we did not observe differences between faecal concentrations of D-aa in WT and mutant mice ( Supplementary Fig. 1i,j) . Together, these data demonstrate that intestinal DAO can regulate the abundance of its substrate D-aa in a region-specific manner. Because oxidative deamination of D-aa by DAO yields H 2 O 2 , which is known to have bactericidal activity and to be an important factor in host defence 15 , we tested the effect of DAO +/− D-aa on the growth of several common enteric pathogens. In vitro, purified porcine DAO supplemented with D-Pro or D-Ala had modest cytotoxicity for several organisms that colonize the GI tract, resulting in up to 30-fold reduction in colony forming units (c.f.u.) (Fig. 3a) . However, Vibrio cholerae and V. parahaemolyticus, diarrhoeal pathogens that colonize the SI and cause cholera and enteritis, respectively, were particularly sensitive to DAO and D-Pro. V. cholerae, a non-invasive pathogen that proliferates adjacent to, but does not disrupt, the epithelial barrier, was also susceptible to DAO even without addition of D-aa, probably because the substantial amounts of D-aa it releases 3 enable greater H 2 O 2 production ( Supplementary Fig. 7b ,c). Consistent with this idea, we found that an amino acid racemase-deficient V. cholerae mutant (bsrV), which releases less D-aa than the wt strain 3, 16 and therefore generates less H 2 O 2 in the presence of exogenous DAO ( Supplementary  Fig. 7d ), shows reduced susceptibility to DAO toxicity in the absence of exogenous D-aa ( Supplementary Fig. 7f ). The sensitivity of V. cholerae to DAO (+/-D-aa) was blocked by catalase, an enzyme that destroys H 2 O 2 ( Fig. 3b) , providing further support for the idea that DAO kills V. cholerae via production of H 2 O 2 . In addition, V. cholerae mutants lacking oxyR, which encodes a positive regulator of H 2 O 2 -inducible genes 17 , showed enhanced sensitivity to DAO (Fig. 3b) . Collectively, these findings demonstrate that, in vitro, DAO can exert bactericidal effects on several enteric pathogens through the production of H 2 O 2 from the oxidation of D-aa.
Previous studies have suggested that DAO may contribute to systemic defence against pathogens via the activity of neutrophil DAO 18, 19 . To test whether DAO activity is important to mucosal defence in vivo, we explored the effect of DAO and D-aa on V. cholerae intestinal colonization in streptomycin-treated adult mice. Adult animals were used rather than the infants commonly used to study V. cholerae colonization because infant mice produce markedly less DAO and no detectable secreted DAO ( Supplementary  Fig. 8 ). Strikingly, comparison of V. cholerae intestinal colonization in WT and DAO G181R littermate mice from heterozygote breeders revealed that c.f.u. were ∼1,000 times more abundant in the proximal SI of DAO G181R animals ( Fig. 3c ). In contrast, colonization of the distal SI, which does not express DAO, did not differ for the WT and mutant animals. These data strongly suggest that the presence of DAO has a profound effect on V. cholerae's ability to survive in the proximal SI. To further investigate the effects of D-aa oxidation on mucosal defence, we compared colonization of WT and DAO G181R animals by WT and bsrV V. cholerae. In adult WT mice, the bsrV mutant colonized the proximal/middle SI to a greater extent (∼15×) than did WT V. cholerae. No such increased colonization by the bsrV mutant was detected in infant WT or adult DAO G181R mice (Fig. 3d) . Collectively, these results indicate that enhanced colonization by ΔbsrV V. cholerae is not an intrinsic feature of this strain and is consistent with the idea that V. cholerae survival in vivo is impaired by the presence of active DAO and its microbially generated D-aa substrates. Infection of adult mice with V. cholerae does not induce intestinal pathology, so the effect of DAO on disease cannot be assessed, but DAO is the first intestinal epithelial-derived factor found to restrict V. cholerae intestinal colonization. Our data raise the possibility that DAO plays a general role in protection at the mucosal surface.
To further investigate the effect of DAO on intestinal microbes, metagenomic analysis of 16S rRNA gene sequences was used to characterize the composition of the intestinal microbiota in DAO WT and DAO G181R littermate mice from heterozygote breeders. Although the overall beta-diversity and total numbers of intestinal bacteria did not differ between groups ( Supplementary Fig. 9a,b ), DAO null animals had an increased abundance of Lactobacillales and decreased abundance of Bacteroidales in both the proximal and middle SI (Fig. 4a,b and Supplementary Fig. 9c-e) . The elevated abundance of Lactobacilli in the SI was also detected using fluorescent in situ hybridization ( Supplementary Fig. 9f ). Thus, DAO activity in the intestinal tract modulates the composition of the microbiota as well as the abundance of the cholera pathogen. The increased abundance of commensal Lactobacillales in DAO G181R mice could in principle reflect decreased H 2 O 2 -mediated killing of these commensal organisms. However, Lactobacillales are relatively resistant to H 2 O 2 (ref. 20) and we found that Lactobacillus johnsonii, which was particularly prominent in DAO G181R mice ( Fig. 4c  and Supplementary Fig. 9g ), was not killed when aerobically mixed DAO and D-Ala was added to an anaerobic culture ( Supplementary Fig. 10a ). Thus, additional mechanisms besides direct killing mediated by H 2 O 2 probably contribute to the altered microbiota in the absence of DAO. Such mechanisms may include the capacity of the elevated D-Ala in DAO null animals to support growth of particular bacterial species such as L. johnsonii, an Ala auxotroph 21, 22 ( Supplementary Fig. 10b ). Indeed, PICRUSt 23 /HUMAnN 24 -based comparisons of the potential metabolic capacities of the microbiota found in the small intestine of DAO WT and DAO G181R mice suggest that there is greater potential for D-Ala metabolism in the DAO null animals ( Fig. 4d and Supplementary Fig. 10d ). However, use of D-Ala or other D-aa as nutrients is unlikely to account for the enhanced growth of V. cholerae in the DAO G181R mice, because supplementation of in vitro cultures with D-Ala did not alter the growth of the pathogen (Supplementary Fig. 10c ).
Secretory immunoglobulin A (sIgA) has been shown to be an important host factor in determining the relative proportions of commensal bacteria in the gut 25 . To determine whether differences in commensal-specific IgA contributed to the observed differences in microbiota composition between WT and DAO G181R mice, we performed IgA-SEQ 26 . We did not observe differences between the composition of faecal IgA-positive bacteria in the DAO WT and DAO G181R mice ( Supplementary Fig. 11a-c) . Notably, however, the lack of DAO activity was associated with approximately twofold higher faecal IgA and increased numbers of small intestinal IgA-positive cells than in DAO WT mice ( Fig. 4e and Supplementary  Fig. 11d ). Antibiotic treatment significantly reduced the faecal IgA levels, abolishing the difference between DAO WT and DAO G181R mice (Fig. 4e) , excluding the possibility of an intrinsic IgA increase in DAO-null mice. Increased sIgA levels have also been observed in mice with reduced innate host defence 27, 28 and thus may reflect impaired mucosal defence in DAO G181R animals. Collectively, our findings reveal that DAO is a microbiotaregulated host innate immune factor that modulates the growth of both pathogens and commensals, primarily in the small intestine. Given the protein's distribution and dependence on oxygen, DAO probably limits bacterial growth close to the absorptive epithelial surface. The enzyme DAO probably regulates the intestinal microbial compartment by several means, including via production of H 2 O 2 , and modulation of its activity may provide a means for controlling microbial homeostasis ( Supplementary Fig. 12 ).
Methods
Antibodies. Polyclonal antiserum against a C-terminal epitope (CLEEKKLSRLPPSHL) of mouse DAO was generated in rabbits and affinitypurified (GenScript) (validated in Supplementary Fig. 2c ). Goat polyclonal antiserum to human DAO (EB11100) was obtained from Everest Biotech. A rabbit monoclonal antibody to GAPDH (14C10) was purchased from Cell Signaling Tech. Goat polyclonal antiserum to Mucin 2 was purchased from Santa Cruz Biotech (H-300). A goat polyclonal anti-mouse IgA antibody conjugated with fluorescein isothiocyanate (FITC) was obtained from Sigma-Aldrich.
Animals. All animal experiments were performed in accordance with a protocol approved by the Harvard IACUC. DAO G181R mice on the ddY background 13 were a gift from R. Konno. The ddY/ DAO G181R mice were backcrossed with C57BL6 mice (Jackson Laboratory) more than ten times. All DAO G181R mice and DAO WT mice used in this study were the offspring of heterozygote breeders (mixed sex).
GF C57BL6 male mice were obtained from the Harvard Digestive Disease Center Gnotobiotic and Microbiology Core. C57BL6 male mice from Jackson Lab were used as SPF mice. Six-week-old GF mice were conventionalized (GF-SPF mice) by placing the mice in cages with bedding from SPF mice. The GF-SPF vancomycin-treated mice (GF-SPF-V) were conventionalized similarly to GF-SPF mice but with vancomycin (0.5 g l , Sigma-Aldrich) in their drinking water for two weeks.
To test the effect of vancomycin on DAO expression in adult SPF, C57BL6 mice (6 weeks old) were treated with 0.5 g l -1 vancomycin in their drinking water for two weeks.
MyD88 knockout (B6.129P2(SJL)-Myd88
tm1.1Defr /J; 8 weeks old, male) and RIPK2 knockout (B6.129S2-Ripk2 tm1Flv /J; 8 weeks old, male) mice were purchased from Jackson Lab, and C57BL6 mice (8 weeks old, male) from Jackson Lab were used as their control. Genotypes of the knockout mice were determined according to Jackson Lab's genotyping protocols.
Isolation of luminal, mucosal and epithelial layers in the small intestine. Slightly modified versions of protocols described by Vaishnava et al. 27 were used to isolate luminal and mucosal layers in the small intestine. The protocol of Roche 30 was followed for isolation of the epithelial layer.
Freshly dissected small intestines were divided equally into three parts (proximal, middle and distal) and each part was further subdivided into three pieces. 'Luminal contents' of each piece were washed out with 2 ml of ice-cold sterile PBS, which resulted in 6 ml of luminal washout for each region. The tissue pieces were opened longitudinally and placed in 15 ml conical tubes with 2 ml of ice-cold sterilized PBS. Tubes were inverted 20 times and vortexed for 10 s and the liquid was then collected in a fresh tube and defined as 'mucosal content'. The remaining tissue pieces were further cut into approximately 3-5 mm square patches, gathered in a 15 ml conical tube with 10 ml of an isolation buffer (0.5 mM dithiothreitol (DTT)/5 mM EDTA in PBS), and incubated with constant shaking at 37°C for 20 min. The epithelial cells were collected by pipetting ten times with a 10 ml pipet and the sample was filtered through a 70 µm cell strainer (Corning) to remove tissue fragments. The cells in suspension were pelleted by centrifugation at 6,000g at 4°C for 10 min and defined as the 'epithelial layer'.
Determination of D-and L-amino acid levels by two-dimensional HPLC. Caecal luminal contents were scooped out and mixed with a 20-fold vol/wt of ice-cold sterile PBS, incubated on ice for 30 min, vortexed for 10 s, and centrifuged at 4°C at 8,000g for 5 min. For amino acids in chow, pellets were mixed with 20-fold vol/wt of ice-cold sterile PBS, kept on ice for 30 min, homogenized by bead-beating and centrifuged at 4°C at 13,000g for 5 min. Supernatants were stored at −80°C until use. For amino acids in small intestinal layers, luminal/mucosal contents in PBS were centrifuged at 4°C at 6,000g for 5 min and epithelial pellets were homogenized in 300 µl PBS and centrifuged at 4°C at 12,000g for 5 min; their supernatants were stored at −80°C until used.
D-and L-amino acid concentrations in the PBS solutions were determined using a two-dimensional HPLC-based method as described 8, 31 with some minor modifications. Briefly, PBS homogenates (20 µl) were mixed with 20 µl H 2 O and 360 µl methanol. The mixture was vortexed vigorously and centrifuged at 4°C to obtain supernatant. Aliquots of the supernatant (10 µl for caecal contents and 100 µl for SI samples) were dried under reduced pressure and the residues were re-dissolved in 20 µl of 200 mM Na-borate buffer (pH 8.0). The amino acids were then derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) by adding 5 µl of 40 mM NBD-F (in acetonitrile) and heated at 60°C for 2 min. After adding 75 µl of 0.1% trifluoroacetic acid in H 2 O, 2 µl of the reaction mixture was subjected to the two-dimensional HPLC system (NANOSPACE SI-2 series, Shiseido) combining a capillary-monolithic octadecylsilyl (ODS) column (0.53 mm inner diameter (ID) × 1,000 mm, prepared in a fused-silica capillary, provided from Shiseido) and a narrowbore-enantioselective column (KSAACSP-001S, 1.5 mm ID × 250 mm, self-packed, material was provided from Shiseido, or Sumichiral OA-3200S, 1.5 mm ID × 250 mm, self-packed, material was provided from Sumika Chemical Analysis Service). The ODS column yielded fractions of NBD-derivatized amino acids as D plus L mixtures and the enantiomers were further separated and determined by narrowbore-enantioselective columns. Fluorescence detection of the NBD-amino acids was carried out at 530 nm with excitation at 470 nm.
Histology. DAO enzyme histochemistry and multiple fluorescence staining. Activitybased DAO labelling was performed similarly to a previously reported method 11 . Deeply anaesthetized mice were perfused transcardially with ice-cold PBS and subsequently with 2% paraformaldehyde in PBS. Tissues were dissected and cryoprotected in 20% sucrose in PBS at 4°C until they sank. They were frozen in a mixture (2:5) of 20% sucrose in PBS and Tissue-Tek OCT Compound (Sakura Finetek). Sections (10 µm) were sliced on a cryostat (Leica) at −24°C and stored at −80°C until they were used. Sections were rinsed in PBS and immersed in DAOactivity staining solution (7 mM sodium pyrophosphate pH 8.3, 0.1% horseradish peroxidase, 0.065% sodium azide, 0.6% nickel ammonium sulfate, 22 mM D-Pro (or L-Pro as a negative control), 20 µM flavin adenine dinucleotide (FAD) and FITCtyramide (1:400; Perkin-Elmer)) for 10 min.
For multiple staining, the sections were rinsed in PBS twice and then incubated in PBS containing 5 unit ml Image analysis. The intensity of cellular DAO fluorescence was quantified with ImageJ. The signal intensities in enterocytes and goblet cells were measured, divided by cellular dimensions and standardized with the averaged value of intensity/area in the control region for enterocytes.
Western blotting. COS7 cells transfected with plasmids (pFLAG-CMV5) encoding cDNA of mouse or human DAO, or epithelial cells isolated from the small intestine, were homogenized in a lysis buffer (150 mM sodium chloride, 1.0% NP-40, 50 mM Tris (pH 8.0) and a protease inhibitor cocktail, complete EDTA-free, Roche) and spun down at 15,000g at 4°C for 5 min. A cerebellar lysate was used as a positive control and cerebral cortical lysate as negative control. Supernatants were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and protein was transferred to nitrocellulose membranes. Blots were blocked in 5% skim milk in Trisbuffered saline with 0.1% Tween-20 (TBST) with constant shaking for 1 h. The membranes were rinsed in TBST and immersed in TBST with an appropriate primary antibody at 4°C overnight. Membranes were subsequently rinsed in TBST, then incubated with an appropriate secondary antibody conjugated with horseradish peroxidase for 1 h. The membranes were rinsed in TBST and bound antibodies detected with SuperSignal West Pico (Thermo Scientific). For the quantification of protein levels, the density of each band was measured using ImageJ 1.49c and DAO expression was standardized with that of GAPDH.
Bacterial strains, growth media and conditions. All V. cholerae strains are derivatives of El Tor clinical isolate N16961 (ref. 32). The oxyR deletion mutant was generated using standard allele replacement protocol 33 with a derivative of the suicide plasmid pCVD442. The ΔbsrV strain has been described previously 3 . Listeria monocytogenes (mutant strain Lm 10403S InlA m ) 34 was grown in brain heart infusion broth (BHIB). Lactobacillus johnsonii (wild-type strain, VPI7960) 35 was cultured in MRS broth (MRSB) unless otherwise described. The remaining bacterial strains, including Enterohaemorrhagic E. coli (wild-type strain, EDL933) 36 , Salmonella enterica serovar Typhimurium (wild-type strain, ATCC 14028), Vibrio parahaemolyticus (wild-type strain, VP47) 37 , Staphylococcus aureus (wildtype strain, MT8) 38 and Pseudomonas aeruginosa (wild-type strain, PA01) 39 were grown in Luria broth (LB) at 37°C. DAO bactericidal activity. Overnight cultures of the tested strains were diluted 500-fold in LB or BHIB and incubated with constant shaking at 37°C with or without 500 µM D-Ala or D-Pro in the presence or absence of 100 µg ml -1 porcine DAO (Sigma-Aldrich). For rescue from DAO toxicity, 50 µg ml -1 bovine catalase (Sigma-Aldrich) was added to the diluted overnight culture. The strains receiving various treatments were aerobically grown until the optical density at 600 nm (OD 600 ) of the control (vehicle treated) sample reached 0.10 (∼2 h). The cells were then serial diluted, plated and incubated at 37°C.
V. cholerae intestinal colonization. Streptomycin-resistant wild-type and ΔbsrV V. cholerae were cultured in LB medium overnight at 26°C. The cultures were pelleted and then resuspended in 2.6% (wt/vol) NaHCO 3 to OD 600 = 1.5. Either 4-month-old DAO WT or DAO G181R , 7-week-old C57BL6 mice (male) or 5-day-old suckling C57BL6 mice (mixed sex) were orogastrically inoculated with ∼2 × 10 8 (for adults) or 1 × 10 6 (for infants) c.f.u. of WT or ΔbsrV V. cholera, as described 40, 41 . Before inoculation of the adult mice, they were treated for 24 h with streptomycin (5 g l -1 , Life Technologies) in their drinking water. The inoculated adult mice were fed ad libitum and provided with water containing 0.2 g l -1 streptomycin. Suckling mice were not treated with streptomycin. After 24 h, the animals were euthanized and the proximal two-thirds of small intestines were dissected, homogenized in 5 ml, serial-diluted, plated and incubated at 37°C on LB agar plates with 200 µg ml -1 streptomycin. The c.f.u. were counted and normalized to the weight of the tissue.
16S rRNA gene sequencing and analysis. Intestinal luminal or mucosal contents were homogenized in tenfold vol/wt PBS with stainless steel beads (3.2 mm diameter, Biospec) using a bead-beater (Biospec) for 20 s. A mixture of 300 µl of the homogenate, 400 µl of an extraction buffer (200 mM Tris pH 8.0, 200 mM NaCl, 20 mM EDTA), 50 µl of 10% SDS, a 300 µl slurry of glass beads (0.1 mm diameter, Biospec) and 500 µl of PCI solution (phenol:chloroform:isoamyl-alcohol, 25:24:1; Invitrogen) was further homogenized by the bead-beater (Biospec) for 3 min and spun down at 14,000g for 5 min. Subsequently, 500 µl of the supernatant was mixed with the same volume of chloroform, vortexed for 10 s, and centrifuged at 14,000 g for 5 min. The DNA was precipitated by adding 300 µl of isopropanol to 300 µl of the aqueous phase, pelleted by centrifugation at 14,000g for 5 min and resuspended with 100 µl of 10 mM Tris-HCl (pH 8.5). The DNA extract was then mixed with five volumes of PB solution (QIAGEN) and purified with a Spin Smart column (CM 400-50, Denville). After washing the column with PE solution (QIAGEN), bacterial genomic DNA was eluted with 10 mM Tris-HCl (pH 8.5). Then, the V3-V4 region of 16S ribosomal RNA was PCR amplified (12.5 ng purified DNA per reaction; Phusion polymerase, New England Biolab) for 25 cycles (95°C for 30 s, 50°C for 30 s and 72°C for 30 s) (primer pair: 341F/805R 42 with overhang adapters) (adapter-341F: 5′-tcg tcg gca gcg tca gat gtg tat aag aga cag CCT ACG GGN GGC WGC AG-3′; adapter-805R: 5′-gtc tcg tgg gct cgg aga tgt gta taa gag aca gGA CTA CHV GGG TAT CTA ATC C-3′). PCR products were purified (MinElute, QIAGEN) and resuspended in 25 µl of 10 mM Tris-HCl pH 8.5. The V3-V4 PCR products were indexed with the Nextera XT Index kit (Illumina) by PCR (2.5 µl PCR product; Nextera XT Index primers; Phusion polymerase) for eight cycles (95°C for 30 s, 55°C for 30 s, and 72°C for 30 s). The 16S rRNA amplicons with indices were purified (MinElute, QIAGEN), resuspended in 25 µl of 10 mM Tris-HCl pH 8.5, quantified with a Qubit 2.0 Fluorometer (Life Technologies), pooled at a concentration of 4 nM, denatured, diluted to a final concentration of 4 pM and sequenced using the MiSeq Reagent Kit v3 (600-cycle, paired-end, Illumina) on a MiSeq sequencer (Illumina).
Paired end reads were initially demultiplexed using MiSeq Reporter v2.0, merged with FastqJoin and quality filtered with a Q-score cutoff of 20. The closed-reference OTU picking workflow in QIIME (versions 1.8 and 1.9) and the Greengenes reference database were used to cluster the reads into 97% identity operational taxonomic units (OTUs). The May 2013 Greengenes taxonomy was used to assign taxonomy to representative OTUs 43, 44 . For analysis including samples from wt and DAO G181R mice, samples were subsampled to 70,000 reads per sample. OTUs with less than 0.005% frequency were filtered out of the OTU tables 45 . Diversity analysis was performed with QIIME. The Linear Discriminant Analysis Effect Size (LEfSe) Galaxy module (http://huttenhower.sph.harvard.edu/galaxy/) was used for additional statistical analysis 29 . Significance levels for LEfSe were P < 0.05 and linear discriminant analysis (LDA) was >2.0. The relative abundance of taxa found significant in LEfSe was further analysed with a Wilcoxon rank-sum tests using Prism (Graphpad Software). Species-level analysis of Lactobacillus was performed with 16S Metagenomics v1.0.1, an application in the BaseSpace (Illumina).
For inference of metagenomic information from 16S amplicon sequencing data, the algorithm PICRUSt (phylogenetic investigation of communities by reconstruction of unobserved states, 23 Galaxy module) was performed using default settings. The resulting metagenomic data were submitted for further analysis to the HMP unified metabolic analysis network (HUMAnN) 24 pipeline (version 0.99) to determine the presence/absence and abundance of microbial pathways by sorting individual genes into Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The LEfSe was used for statistical analysis of outputs from HUMAnN (significance levels: P < 0.05 and LDA score >2.0).
Enzyme-linked immunosorbent assay for faecal IgA. Six-week-old DAO wt and DAO G181R mice were treated with a mixture of antibiotics (1 g l -1 ampicillin, 1 g l
neomycin, 1 g l -1 metronidazole and 0.5 g l -1 vancomycin) for one week and then with the same antibiotics at one-half the initial concentrations for two additional weeks in their drinking water. Antibioics were diluted in 5% sucrose, which was used as vehicle control. Faeces were homogenized in a 10× volume (vol/wt) of PBS containing a protease inhibitor cocktail, Complete EDTA-free (Roche), using a bead-beater (Biospec) for 20 s and centrifuged at 3,000 r.p.m. for 15 min at 4°C. Supernatants were further spun down at 10,000 r.p.m. for 5 min at 4°C and the IgA level in the final supernatant was determined using the Mouse IgA ELISA Ready-SET-Go! kit (eBioscience), according to the manufacturer's protocol. Faecal IgA levels were standardized per weight of faeces.
Statistics. No statistical methods were used to predetermine sample size for animal experiments. The sample size for experiments of V. cholerae colonization in mice was based on previous studies 40, 41 . Animal experiments (Fig. 2g, 3c, 4a-d) were performed blind to group allocations. Blinding was not possible for other animal experiments. No randomization was used. Prism (Graphpad software) was used for data plotting and statistical analyses. Statistical significance was determined by oneway ANOVA with the Tukey post-test when more than two groups with normal distribution were compared (Figs 2f, 3a,b) , or with the Wilcoxon rank-sum test to compare two groups when data were not normally distributed (Figs 2g, 3c,d, 4b,d,e) .
Accession codes. 16S rRNA sequences, generated from intestinal samples in raw format before post-processing and data analysis, have been deposited at the European Nucleotide Archive (accession no. PRJEB12079).
